| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $332,174 ) |
| | 2024 | 2024 | FLUIDDA INC | 228 E 45TH ST RM 9E | NEW YORK | NY | 10017-3337 | NEW YORK | USA | U01FD007987 | A prospective study to support validation of lung deposition models with nuclear medicine imaging methods | 001 | 2 | FDA | 9/5/2024 | $332,174 |
| | 2024 | 2023 | FLUIDDA INC | 228 E 45TH ST | NEW YORK | NY | 10017-3303 | NEW YORK | USA | U01FD007987 | A prospective study to support validation of lung deposition models with nuclear medicine imaging methods | 000 | 1 | FDA | 10/25/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $332,947 ) |
| | 2023 | 2023 | FLUIDDA INC | 228 E 45TH ST | NEW YORK | NY | 10017-3303 | NEW YORK | USA | U01FD007987 | A prospective study to support validation of lung deposition models with nuclear medicine imaging methods | 003 | 1 | FDA | 9/26/2023 | $332,947 |
| | 2023 | 2023 | FLUIDDA INC | 228 E 45TH ST | NEW YORK | NY | 10017-3303 | NEW YORK | USA | U01FD007987 | A prospective study to support validation of lung deposition models with nuclear medicine imaging methods | 002 | 1 | FDA | 9/21/2023 | $332,947 |
| | 2023 | 2023 | FLUIDDA INC | 228 E 45TH ST | NEW YORK | NY | 10017-3303 | NEW YORK | USA | U01FD007987 | A prospective study to support validation of lung deposition models with nuclear medicine imaging methods | 003 | 1 | FDA | 9/26/2023 | -$332,947 |
| | 2023 | 2023 | FLUIDDA INC | 228 E 45TH ST | NEW YORK | NY | 10017-3303 | NEW YORK | USA | U01FD007987 | A prospective study to support validation of lung deposition models with nuclear medicine imaging methods | 001 | 1 | FDA | 9/20/2023 | -$332,947 |
| | 2023 | 2023 | FLUIDDA INC | 228 E 45TH ST | NEW YORK | NY | 10017-3303 | NEW YORK | USA | U01FD007987 | A prospective study to support validation of lung deposition models with nuclear medicine imaging methods | 000 | 1 | FDA | 9/12/2023 | $332,947 |
|
|
